Express News | HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $15 Price Target
Biora Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/22/2024 2015.95% HC Wainwright & Co. $15 → $15 Reiterates Buy → Buy 05/16/2024 2015.95% HC Wainwright &
Biora Therapeutics Buy Rating Confirmed by Positive Phase 1 Trial Outcomes and NaviCap Technology Potential
Biora Therapeutics Advances Ulcerative Colitis Treatment With BT-600 Trial Success
Express News | Biora Therapeutics Announces Supplemental Data From Phase 1 Clinical Trial of BT-600 as Presented at Kol Event
Biora Therapeutics to Host Virtual KOL Event on NaviCap Targeted Oral Delivery Platform and Results From Phase 1 Clinical Trial of BT-600 on July 17, 2024
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event to be held on Wednesday,
Biora Therapeutics Reports Positive Data For Trial Of BT-600 In Ulcerative Colitis
Express News | Biora Therapeutics Inc: BT-600 Was Well Tolerated and Met All Trial Objectives
Express News | Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
Express News | Biora Therapeutics-Entered Into Equity Distribution Agreement, Co May Offer & Sell From Time to Time up to $90 Mln of Shares of Co’s Common Stock
12 Health Care Stocks Moving In Monday's After-Market Session
GainersASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 11.9% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Biora Therapeutics (NASDA
Express News | Biora Therapeutics:Staff Notified Co That Its Securities Were Subject to Delisting From Nasdaq Unless Company Timely Requests Hearing Before Panel
Express News | Biora Therapeutics Inc - Company Did Not Regain Compliance With Nasdaq's Mvls Rule by June 10, 2024
Biora Therapeutics Announces Presentation on the BioJet Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical data from the
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast fo
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersCue Health (NASDAQ:HLTH) shares moved upwards by 42.1% to $0.13 during Friday's pre-market session. The company's market cap stands at $21.3 million. Innovative Eyewear (NASDAQ:LUCY) stock rose
Express News | Biora Therapeutics Inc Files for Resale of up to 2.23 Mln Common Shares by the Selling Stockholders - SEC Filing
Express News | Biora Therapeutics Inc Files for Mixed Shelf of up to $200 Mln - SEC Filing
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap Platform at Digestive Disease Week 2024
Four clinical device performance studies successfully demonstrate the NaviCap platform's ability to deliver therapeutics directly to the colon under variable GI conditions and eating schedulesSAN DIEG
Express News | HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $15 Price Target